Donald Rose

Don Rose is a Venture Partner to Hatteras Venture Partners.
He has extensive experience in launching and building life science startups, most recently as Director of the University of North Carolina’s KickStart program.
At UNC, he helped spin out 80 companies which have gone on to raise over $500M.
While at UNC, he published Research to Revenue: A Practical Guide to University Start-ups (UNC Press, 2016)).
In addition, he’s a Professor of the Practice at UNC’s Kenan-Flagler Business School, teaching entrepreneurship.
Prior to UNC, he held senior leadership roles at a number of life science startups: Metabolon (metabolomics), Deerac Fluidics (nanoliter dispensing), and DataCentric Automation (high-throughput crystallography).
Before that, he was a partner with Catalysta Partners (now Hatteras Venture Partners), where he co-founded Phase Bioscience (NASDAQ: PHAS).
Prior to Catalysta, he was co-founder and VP of Research and Development at Cartesian Technologies, a leader in instrumentation for DNA microarrays and nanoliter dispensing.
Prior to Cartesian, Dr. Rose was a research scientist at Glaxo Wellcome (now GSK) where he developed and promoted a number of technologies in bioanalytical chemistry, combinatorial chemistry and high-throughput screening.
Prior to GW, Dr. Rose developed various aspects of capillary electrophoreses instrumentation at Hewlett-Packard Laboratories.
Dr. Rose received his Ph.D.
in Analytical Chemistry and BS in Nutrition from the University of North Carolina.
He holds six US patents and has published eight papers, and two book chapters.